iTonic (ITOC) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Precision Optics (POCI) has outperformed iTonic (ITOC) over the past year, losing 10.4% versus a loss of 82.0%. Precision Optics is the larger company by market cap ($45.3 million vs $11.6 million), about 3.9 times the size. Precision Optics converts more of its revenue into profit, with a net margin of -11.5% versus -974.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITOC | POCI |
|---|---|---|
| Share price | $1.59 | $4.12 |
| Market cap | $11.63M | $45.30M |
| 1-day change | +6.00% | +1.41% |
| YTD return | -76.40% | -1.67% |
| 1-year return | -81.96% | -10.43% |
| 5-year return | — | -37.86% |
| Forward P/E | — | 206.00 |
| EPS (TTM) | $-4.22 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $523.03K | $31.53M |
| Revenue growth (YoY) | +16.70% | +65.16% |
| Net income (latest FY) | $-5.10M | $-3.63M |
| Gross margin | 62.59% | 17.22% |
| Operating margin | -991.71% | -11.13% |
| Net margin | -974.68% | -11.51% |
| 52-week high | $18.40 | $6.15 |
| 52-week low | $1.40 | $3.55 |
| Distance from 52-week high | -91.36% | -33.01% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +94.17% |
| Average volume | 42.84K | 43.00K |
| Shares outstanding | 6.84M | 10.99M |
| Employees | 7 | 108 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Precision Optics is about 3.9 times larger than iTonic by market value ($45.30M vs $11.63M).
- POCI has outperformed ITOC by 71.5 percentage points over the past year.
- Precision Optics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -974.7 cents for iTonic.
- Precision Optics grew revenue faster in its latest fiscal year (+65.16% vs +16.70%).
About iTonic
ITOC stock →iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 7 employees
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
ITOC vs POCI FAQ
Which is bigger, iTonic or Precision Optics?
Precision Optics (POCI) is larger, with a market capitalization of $45.30M compared with $11.63M for iTonic (ITOC).
Which stock has performed better over the past year, ITOC or POCI?
POCI returned -10.43% over the past 12 months, compared with -81.96% for ITOC (price return, excluding dividends). Past performance does not predict future results.
Are iTonic and Precision Optics in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.